| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$156,124,463 |
|
|
|
Indirect Value
|
$362,246,186 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$518,370,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDA |
Clinical Data Inc |
Director |
– • • |
2007-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,460 |
1,620,946 |
0 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-09-24 |
4 |
A |
$3.50 |
$74,998 |
I/I |
21,428 |
13,517,050 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-08-29 |
4 |
B |
$2.60 |
$59,800 |
I/I |
23,000 |
498,300 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2007-09-19 |
4 |
B |
$9.00 |
$207,765 |
I/I |
23,085 |
3,970,000 |
2.25 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2018-08-28 |
4 |
S |
$0.41 |
$10,086 |
I/I |
(24,600) |
27,151 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,876 |
3,504,876 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-02-28 |
4 |
A |
$7.97 |
$199,999 |
I/I |
25,094 |
16,108,845 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-16 |
4 |
B |
$5.73 |
$147,834 |
I/I |
25,800 |
243,964 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-01-31 |
4 |
A |
$7.66 |
$199,995 |
I/I |
26,109 |
16,083,751 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
26,374 |
1,015,626 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • • |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
26,661 |
122,309 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2015-12-01 |
4 |
A |
$35.34 |
$999,987 |
I/I |
28,145 |
22,637 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$5.51 |
$157,845 |
I/I |
28,463 |
1,299,886 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-04-29 |
4 |
A |
$26.73 |
$999,963 |
I/I |
28,556 |
149,622 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-03-31 |
4 |
A |
$33.89 |
$999,963 |
I/I |
29,299 |
128,548 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2007-03-14 |
4 |
B |
$7.91 |
$238,882 |
I/I |
30,200 |
522,460 |
1.5 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-09-08 |
4 |
B |
$2.52 |
$76,860 |
I/I |
30,500 |
561,100 |
1.5 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-09-13 |
4 |
B |
$15.42 |
$471,405 |
I/I |
30,571 |
642,834 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-11-30 |
4 |
A |
$29.18 |
$999,974 |
I/I |
31,348 |
5,288,980 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-05-13 |
4 |
B |
$15.63 |
$500,457 |
I/I |
32,019 |
829,379 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
I/I |
32,425 |
19,037,059 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2015-12-31 |
4 |
A |
$30.15 |
$999,964 |
I/I |
32,674 |
48,678 |
0 |
- |
|
| PGEN |
Precigen Inc |
Executive Chairman |
• • • |
2020-01-31 |
4 |
A |
$6.02 |
$200,002 |
I/I |
33,223 |
18,528,842 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-02-29 |
4 |
A |
$29.67 |
$999,991 |
I/I |
33,425 |
105,150 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2016-12-13 |
4 |
B |
$28.90 |
$1,000,113 |
I/I |
34,606 |
213,805 |
2.64 |
- |
|
271 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
